FDA 483 - Lonza Houston, Inc - November 18, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Lonza Houston, Inc. in Houston, TX, received a Form 483 for significant deficiencies in its aseptic processing areas, primarily concerning microbial contamination control. The inspection revealed numerous environmental monitoring excursions, adverse trends of mold and bacterial recoveries, and subsequent impact on drug substance batches. Additionally, the firm failed to adequately extend investigations of discrepancies to all potentially affected drug product batches.
ID · e418f58e-2cfe-4e4a-b05c-26a75097a51a